AzTrials
AzTrials

Postoperative Nausea and VomitingSPOR-PONVNCT04433676

Early PONV - a Registry Based Study in Sweden.

An observational study of Postoperative Nausea and Vomiting and Postoperative Complications, run by Jakob Wallden at 1 site in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The study is an registry study based on data from the Swedish Perioperative Registry (SPOR) during the years 2016-2022 with the aim to explore the risk for postoperative nausea and vomiting at the recovery unit (early PONV). Read more about this study

Who is it for?
Ages 18 years and older
How many people
1,500,000 participants
Where
1 siteSweden
Study dates
1 Jan 2016to 31 Dec 2029
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Registry data of patients with surgical procedures under general or regional anesthesia in Sweden 2016-2022.

Who may be able to join

  • Procedure under general or regional anaesthesia
  • Age >=18 years at the day of the procedure.

Who cannot join

  • No entry of the PONV-variable in the SPOR-registry

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jakob Wallden, MD PhD contact

0046703644392

jakob.wallden@umu.se

Sweden1 site, 1 recruiting
  • Västernorrland County Council / Sundsvall Hospital

    Sundsvall, X, 851 86

    Jakob Wallden, M.D. PhD., +46703644392, jakob.wallden@umu.se

    Antonio Moraitis, M.D. Ph.D., antonio.moraitis@rvn.se

    Recruiting

Other trials in Sweden

About this study

Official title: Risk of Early Postoperative Nausea and Vomiting (PONV) - a Study With Data From the Swedish Perioperative Register (SPOR).

The study is an registry study based on data from the Swedish Perioperative Registry (SPOR) during the years 2016-2022 with the aim to explore the risk for postoperative nausea and vomiting at the recovery unit (early PONV). The study will explore several cohorts (for example a specific procedure) on a national basis, report the risk for early PONV and identify associated factors.

Read the detailed description

The study is a registry study based on data from the Swedish Perioperative Registry (SPOR) during the years 2016-2022 with the aim to explore the risk for postoperative nausea and vomiting at the recovery unit (early PONV).

Almost all hospitals in Sweden report surgical procedures to SPOR and for the years 2016-2019 there are almost 1.7 million procedures in the registry for patients >18years. Data will be extracted from SPOR on a yearly basis and results will be reported on selected cohorts (time periods and/or type of surgical procedure) during the study period.

There is an option for hospitals to register nausea and vomiting occurring at the recovery unit and submit the data to SPOR. If a hospital choose to use the variable in their dataset, all patients at their unit needs to be registered either with [No_Nausea or Vomiting], [Nausea] or [Nausea or Vomiting]. In the year 2019, more than 50% of procedures under anesthesia in the registry had registration of PONV. The strength with this system is that if a unit uses the variable, all cases will be classified either as "noPONV" or "PONV".

The investigators aim to use the variable PONV at the recovery unit to describe the risk for early PONV and explore associated factors in several cohorts of surgical procedures in Sweden.

The first dataset (2016-2018) was sent to the investigators from the SPOR registry in May 2019 and during the period June 2019- May 2020, the dataset was used to build up a model for the analysis of data with a preliminary report of elective surgeries in Sweden the year 2017.

An updated dataset (all cases 2016-2025) was retrieved from SPOR in June 2026 and further analysis and reporting is based on the most updated dataset (yearly basis until 2029).

Being tested
no intervention
Medical subject headings
Postoperative Nausea and Vomiting, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • no interventionOther

Study groups in NCT04433676
Study groupRoleWhat they receive
Patients with surgical proceduresAdult patients undergoing surgical procedures under general or regional anesthesia and with an admission to a recovery unit for the initial postoperative care.
Receives: Other: no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PONV

    Nausea or Vomiting

    Measured: At the recovery unit, up to 24 hours after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2020
  2. Study start1 Jan 2016
  3. Primary completion31 Dec 2029 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
1,500,000 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT04433676
Sponsor's protocol ID
SPOR-PONV 1.0
Acronym
SPOR-PONV
Status last verified
Aug 2026
First submitted
10 Jun 2020
Last updated
19 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Our dataset includes a large set of registry data, and we are not sure if we legally are allowed to share these data.

Publications

  • Wallden J, Larsson M, Moraitis A, Ahlqvist S, Cengiz Y, Myrberg T, Nystrom H, Hultin M. Early Postoperative Nausea and Vomiting After Bariatric Surgery: A Study of 8426 Patients from the Swedish Perioperative Registry (SPOR). Obes Surg. 2025 Dec;35(12):5308-5315. doi: 10.1007/s11695-025-08351-0. Epub 2025 Nov 4.

    PubMed 41188673

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Nausea and Vomiting and Postoperative Complications, run by Jakob Wallden at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jakob Wallden, MD PhD (0046703644392, jakob.wallden@umu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PONV (time frame: At the recovery unit, up to 24 hours after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04433676, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Early PONV - a Registry Based Study in Sweden. | AzTrials